The objective of the present study was to delineate the molecular mechanisms for mitochondrial contribution to oxidative stress induced by hypoxia and reoxygenation in the heart. The present study introduces a novel model allowing real-time study of mitochondria under hypoxia and reoxygenation, and describes the significance of intramitochondrial calcium homeostasis and mitochondrial nitric oxide synthase (mtNOS) for oxidative stress. The present study shows that incubating isolated rat heart mitochondria under hypoxia followed by reoxygenation, but not hypoxia per se, causes cytochrome c release from the mitochondria, oxidative modification of mitochondrial lipids and proteins, and inactivation of mitochondrial enzymes susceptible to inactivation by peroxynitrite. These alterations were prevented when mtNOS was inhibited or mitochondria were supplemented with antioxidant peroxynitrite scavengers. The present study shows mitochondria independent of other cellular components respond to hypoxia/reoxygenation by elevating intramitochondrial ionized calcium and stimulating mtNOS. The present study proposes a crucial role for heart mitochondrial calcium homeostasis and mtNOS in oxidative stress induced by hypoxia/reoxygenation.
Introduction
Reoxygenation of the hypoxic cardiac tissue (hypoxia/ reoxygenation; H/R) is one of the prime mechanisms underlying cell and tissue damage in pathologic conditions including ischemic heart disease. H/R increases level of oxidative species and attenuation of those species protects cardiomyocytes from H/R-induced damage [1] [2] [3] . Mitochondria remain one of the main cellular sources of oxidative species and play a crucial role in oxidative injury during H/R [4] . Mitochondria produce nitric oxide (NO) via mitochondrial NO synthase (mtNOS) that potently produces oxidative species such as peroxynitrite [5] . mtNOS-derived peroxynitrite causes oxidative modification of mitochondrial components and releases the key mitochondrial pro-apoptotic protein, cytochrome c [6, 7] . During H/R, formation of NO and peroxynitrite is increased that causes cardiac tissue injury [8] , and H/R-induced cardiac injury is diminished when production of peroxynitrite is inhibited [9] . The molecular mechanism by which NO and peroxynitrite contribute to mitochondrial damage during H/R is not fully understood. The present study utilized a novel in vitro model that allows studying isolated mitochondria under hypoxia or H/R. The present study shows that H/R causes mitochondrial cyto-chrome c release, induces oxidative modification of mitochondrial lipids and proteins, and inactivates mitochondrial enzymes susceptible to peroxynitrite. The present study also shows that H/R elevates intramitochondrial Ca 2+ ([Ca 2+ ] m ) that serves as the mechanism underlying stimulation of mtNOS.
Materials and methods

Isolation and purification of mitochondria and mitochondrial subfractions
Intact heart mitochondria were isolated from SpragueDawley rats (200-260 g) as described [10] with additional purification steps. All isolation and purification steps were carried out at 4°C. Euthanasia was performed by decapitation followed by depleting the body of blood to limit exposure of mitochondria to NO reacting molecules such as hemoglobin. The thorax was opened, the heart was excised and placed in 20 ml of ice-chilled solution A, containing MSH buffer pH 7.40 (mannitol, 220 mM; sucrose, 70 mM; HEPES, 10 mM), EDTA (0.2 mM) and fatty acid free bovine serum albumin (0.1%). While in solution A, the heart was gently squeezed to further deplete the organ of blood. The heart was then placed in an ice-chilled Petri dish and dissected along the left descending coronary artery. The aorta, vessels, blood clots, fat, and connective tissues were removed. The heart muscle was washed in solution A and thoroughly minced with a BioHomogenizer M133/1821-0 (Biospec Products) with speed adjusted at position one. The minced tissue was transferred into a glass homogenizing tube (Fisher Scientific) and homogenized in 3 ml aliquots using a Teflon pestle (Fisher Scientific) driven at 750 RPM. To avoid heating the homogenate, the tube was placed in a "cold jacket" filled with ice and cold water. The homogenate was centrifuged for 5 min at 600×g, and the supernatant was centrifuged for 10 min at 10,000×g. The supernatant of the second centrifugation was discarded and the enriched mitochondrial pellet was resuspended in 1 ml MSH. The enriched mitochondrial pellet was layered on a Percoll solution (25%) and centrifuged for 30 min at 100,000×g. The middle layer was extracted and washed twice in MSH for 10 min at 10,000×g. The purified mitochondria pellet was resuspended in 0.5 ml MSH. The purity of the mitochondrial preparation was determined by measuring the cytochrome a content at 605-630 nm using the extinction coefficient of 12 mM − 1 cm − 1 [11] . Only mitochondria with less than 5% impurity were used in this study. Possible contamination of mitochondrial preparation with cytoplasmic proteins was ruled out by the lack of detectable cytoplasmic proteins antibody cross-reactivity in the mitochondrial preparation. The respiratory control ratio of the purified mitochondria was assessed as described [11] . Briefly, purified mitochondria (0.5 mg) were added to a 25°C thermostated chamber containing 1 ml of buffer (pH 7.40) consisting of HEPES (100 mM), MgCl 2 (5 mM), EDTA (0.5 mM), and potassium phosphate (5 mM). At 45 s, 105 s, and 195 s, rotenone (5 μM), K + -succinate (5 mM), and ADP (150 μM)
were added, respectively. The ratio of the state 3 to state 4 respiration rates was calculated. Only mitochondria with a ratio of ≥ 8 were used in this study.
General incubation procedures
Mitochondrial samples (1 mg protein in a final volume of 100 μl HEPES buffer pH 7.10) were incubated for 30 min on ice with occasional gentle shaking in the presence or absence of L-NMMA (100 μM), glutathione monoethyl ester (GME 100 μM [12, 13] ), or Trolox (100 μM; Calbiochem).
In vitro hypoxia and H/R
To obtain hypoxia samples, 1 ml of air-saturated buffer (100 μM HEPES pH 7.10) was added to a 25°C thermostated tightly sealed chamber equipped with an oxygen-sensitive electrode with a 2.0 mm tip (ISO-OXY-2; 1 μM O 2 A protease inhibitor cocktail consisting of leupeptin (Axxora), phenylmethanesulfonyl fluoride, pepstatin A (Axxora), and aprotinin (Sigma) (10 μM each) [6, 14] was present in the buffer during hypoxia or H/R. After hypoxia or H/R was completed, cytochrome c was detected by Western blot as described [6] .
Lipid peroxidation (LPO)
Once hypoxia or H/R was completed LPO was determined using thiobarbituric acid assay as described [7] .
Protein carbonyl formation
Once hypoxia or H/R was completed protein carbonyl formation was measured by the trichloroacetic acid assay as described [15] . The samples were precipitated by adding 1 ml of trichloroacetic acid (10%). The precipitates were suspended in 1 ml of 2,4-dinitrophenyl hydrazine (0.2%; w/v) and incubated at 37°C for 60 min. The samples were re-precipitated with trichloroacetic acid and re-centrifuged. The precipitates of the second centrifugation were washed with ethanol:ethyl acetate (50:50) and dissolved in guanidine hydrochloride (6 mM) in phosphate buffer pH 6.50. The protein carbonyls were measured at 370 nm and expressed as pmol per mg mitochondrial protein using ε 370nm 21 mM
2.5. Determination of the activity of mitochondrial enzymes 2.5.1. Aconitase activity Once hypoxia or H/R was completed, broken mitochondria were prepared by freeze-thawing the pellets 3 times in liquid nitrogen followed by adding 4 times ice-cold water containing protease inhibitor cocktail as above. Membrane rupture was tested by lack of transmembrane potential measured as described [16, 17] . The broken mitochondria samples were , inhibited by L-NMMA, or mitochondria were supplemented with peroxynitrite scavengers Trolox or GME. (C) Lipid peroxidation (LPO) and protein carbonylation (PC) were measured in mitochondria treated under hypoxia or hypoxia/reperfusion (H/R) in the absence of L-NMMA, Trolox or GME (LPO; PC) or presence of L-NMMA (LPO NMMA; PC NMMA), Trolox (LPO TROLOX; PC TROLOX) or GME (LPO GME; PC GME). Numbers on the horizontal axes represent oxygen concentration in μM. Norm represents mitochondria sample incubated 40 min under normoxia (air) and Ctrl represents freshly isolated mitochondria. ⁎ Significantly different from control. centrifuged for 20 min at 100,000×g at 4°C. The supernatants, referred as to the soluble fraction, were collected. The aconitase activity of soluble fraction (50 μg) was measured as described [18, 19] by following the OD of cis-aconitate (0.2 mM) as the substrate at 240 nm.
MnSOD activity
Onec MnSOD activity of soluble fraction (30 μg) was measured by the Fridovich method [20] in the presence of KCN (2 mM).
Mitochondrial creatine kinase (mtCK) activity
The mtCK activity of soluble fraction (2.5 μg) was measured by adding phosphocreatine (10 mM) to the coupled system for adenylate kinase and by subtracting the adenylate kinase activity from the result obtained [21] .
Adenylate kinase activity
Adenylate kinase activity of soluble fraction (2 μg) was measured at 340 nm in a reaction mixture containing ADP (1 mM), glucose (20 mM), NADP + (0.5 mM), MgCl 2 (2.5 mM), G6PDH (7.2 U), and hexokinase (6.3 U) as described [22] .
SCOT activity
SCOT activity was measured as described [7] . Soluble fraction (50-100 μg) was added to Tris-HCl (50 mM) pH 8.50 containing succinyl-CoA (0.1 mM), acetoacetate (5 mM), MgCl 2 (5 mM) and iodoacetamide (4 mM) and the formation of acetoacetyl-CoA was followed at 313 nm.
mtNOS activity
Mitochondrial NOS activity was determined by using the citrulline, fluorometric, and chemiluminescence assays [7, 11] .
2.5.6.1. Citrulline assay. Mitochondria were incubated in HEPES buffer supplemented with L-[ 3 H]arginine (30,000-50,000 cpm) in the absence or presence of Ca 2+ (20-80 μM), ruthenium red (10 μM), rotenone (5 μM), L-arginine (100 μM), or MgCl 2 (1 mM). After 20-min incubation, the mtNOS activity was terminated by addition of ice-chilled stop solution and L-citrulline was measured as described [7] . To measure heart mtNOS activity in hypoxia or H/R, the hypoxia or H/R chamber was supplemented with L-[
3 H]arginine and the stop solution was added at the end of hypoxia or reoxygenation. 2.5.6.2. Fluorometric assay. Mitochondria (0.25 mg/ml) were incubated with the membrane-permeable NO-sensitive fluorescent probe, diaminofluorescein diacetate (DAF-2 DA; 5 μM; Calbiochem), excited at 495 nm, and the emission was collected at 515 nm as described [11] .
2.5.6.3. Chemiluminescence assay. Mitochondria (100 μg) were injected into the purge vessel containing vanadium chloride (0.8% in 1 M HCl) thermostated at 95°C, and NO was measured using Chemiluminescence Analyzer (Sievers 280i) as described [7] .
Determination of intramitochondrial calcium concentration
Once hypoxia or H/R was completed, [Ca 2+ ] m was determined in the presence of Arsenazo III using a dual beam spectrophotometer described [7] . The mitochondrial transmembrane potential (Δψ) was collapsed by rotenone (5 μM) and CCCP (1 μM) to allow the [Ca 2+ ] m to equilibrate with extramitochondrial buffer. At the end of the assay, EGTA (5 mM) was added to ensure the test.
A Ca 2+ -sensitive electrode was also used to determine [Ca 2+ ] m for broken mitochondria, as described [23] . In both assays calibration was obtained using known concentrations of Ca 2+ . To measure [Ca 2+ ] m during H/R in a real-time fashion, the recently described highly sensitive fluorometric assay was used [7] . A fluorescent cuvette was equipped with a gas-exchange system and an O 2 sensor (100 μm; O 2 detection limit 0.1-100%; response time b 5 s) that allowed maintaining the [O 2 ] at the desired concentration (Scheme 1). The cuvette containing 2 ml HEPES buffer (100 mM pH 7.10) was purged with N 2 until [O 2 ] reached the hypoxic concentration. 2 mg Mitochondria loaded with 10 μM Fura-2 were added to the cuvette and incubated at hypoxia for 30 min, followed by reoxygenation for 10 min. The [Ca 2+ ] m was monitored during the entire hypoxia and reoxygenation by exciting mitochondria at dual wavelengths of peak minus isosbestic point (352-362 nm) and recording the fluorescence at 510 nm [7] .
Transmembrane potential
The Δψ was supported by K + -succinate (0.8 mM) and determined at 511-533 nm using Safranine (10 μM) as described [17] .
Statistics
Barograms represent mean ± SD of n ≥ 6. Traces are representative of n ≥ 6. Statistical comparison was performed using ANOVA with significance set at P b 0.05.
Results and discussion
H/R induces cytochrome c release and oxidative stress
Release of cytochrome c from the mitochondria is one of the key events during apoptosis [6, 24, 25] . Ischemia-reperfusion induces apoptosis [4] by igniting mitochondrial apoptosis machinery [26] and cytochrome c release [22] . Fig. 1A cellular components respond to H/R. H/R of the heart increases peroxynitrite [9] and causes mitochondrial dysfunction [4] . We and several other groups have shown that mitochondria produce peroxynitrite via mtNOS and that mtNOS-derived peroxynitrite causes release of cytochrome c from the mitochondria [7, 17, 21] . Thus we tested possible role of heart mtNOS in cytochrome c release and mitochondrial oxidative stress during H/R. Fig. 1B shows that cytochrome c release induced by H/R was aggravated when mtNOS was stimulated by elevating [Ca 2+ ] m and inhibited when mtNOS was inhibited by L-NMMA. Trolox, GME, or L-NMMA did not alter cytochrome c release from mitochondria not treated under hypoxia or H/R. Since stimulation of mtNOS induces cytochrome c release and inhibiting mtNOS prevents the cytochrome c release [17] , it is plausible that mtNOS activity was increased during H/R. Fig. 1B shows that H/R-induced cytochrome c release was prevented when mitochondria were supplied with Trolox or GME. Trolox, a hydrophilic alphatocopherol analogue and peroxynitrite scavenger, reduced H/Rinduced oxidative injury in isolated rat hearts [27] , inhibited apoptosis induced by NO [28] , and prevented LPO of heart mitochondrial membranes [29] . Likewise, GME, a glutathione derivative peroxynitrite scavenger [27] , prevented the harmful effects of peroxynitrite in H/R by converting peroxynitrite to an S-nitrosating species [8] . Thus, result presented in Fig. 1B strongly suggests that H/R induces cytochrome c release via mtNOS-derived peroxynitrite. LPO [30] and protein carbonylation [31, 32] are reliable peroxynitrite biomarkers. Fig. 1C shows that while hypoxia did not increase mitochondrial LPO or protein carbonyls, there is a sharp increase in LPO and protein carbonyl levels in mitochondria incubated under H/R. Increases in the LPO and protein carbonyl were fully prevented when mtNOS was inhibited, or mitochondria were supplemented with peroxynitrite scavengers Trolox or GME (Fig. 1C) .
Results presented in Fig. 1 strongly suggest that H/R increases mtNOS activity. Thus, we measured mtNOS activity of mitochondria treated under hypoxia or H/R. As shown in Fig.  1 , incubation of mitochondria at [O 2 ] higher than 50 μM followed or not by reoxygenation did not induce cytochrome c release or oxidative modification of mitochondrial lipids or proteins. Therefore, 50 μM O 2 is hereafter considered as hypoxia and 50 μM O 2 followed by reoxygenation as H/R. Figs.  2A and B show a significant increase in mtNOS activity of H/R samples as compared with the control. This effect of H/R was prevented by L-NMMA. No difference was observed between hypoxia and control samples. These results show that heart mtNOS activity is, indeed, increased during H/R and confirm a recent finding showing that ischemia-reperfusion increases mtNOS activity of kidney mitochondria [21] . In pathologic conditions such as H/R, peroxynitrite inactivates several heart mitochondrial enzymes. To further study possible elevation of mtNOS-derived peroxynitrite during H/R, we tested the activity of mitochondrial enzymes known to be susceptible to peroxynitrite-induced inactivation. Among them are aconitase, a citric cycle enzyme inactivated by reperfusion of isolated heart mitochondria [32] ; mtCK, an enzyme involved in conversion of ADP to ATP that is inactivated by peroxynitrite during reperfusion [33] ; MnSOD [34] , a key enzyme protecting mitochondria against oxidative injury in H/R [2] ; and SCOT, the mitochondrial rate-limiting enzyme in ketolysis [35] that is inactivated by mtNOSderived peroxynitrite [7] . Figs. 2C and D show that all tested enzymes were inactivated by H/R but not hypoxia, and that inactivation of those enzymes was prevented when mtNOS was inhibited. Activity of adenylate kinase, a peroxynitriteinsensitive enzyme, was unaltered (0.0151 ± 0.0011; 0.0149 ± 0.0009; 0.0152 ± 0.0015 μmol min − 1 mg − 1 for control, H/R, and hypoxia, respectively). L-NMMA did not alter the activity of neither enzyme in control samples. These results further suggest the involvement of mtNOS in H/R-induced oxidative stress via peroxynitrite production.
Ca 2+ dependence of heart mtNOS
Several groups have shown Ca 2+ sensitivity of mtNOS in various organs, tissues, and cells [19, [36] [37] [38] . However, an earlier study suggested that mtNOS is not Ca 2+ -sensitive and its activity is stimulated by supplementing mitochondria with Larginine [39] . Fig. 3A shows that rat heart mtNOS activity was stimulated when [Ca 2+ ] m was increased in a concentrationdependent manner. This figure also shows that Ca 2+ -stimulated mtNOS activity was inhibited by L-NMMA, when mitochondrial Ca 2+ uptake was blocked by Ruthenium Red or collapsing Δψ by rotenone. The Ca 2+ stimulated, L-NMMA-sensitive and Ruthenium Red-sensitive NO production was also confirmed using fluorometric NOS assay (Fig. 3B) . These results are consistent with a previous report demonstrating Ca 2+ dependence of mouse heart mtNOS [38] . Fig. 3A also shows that supplementing mitochondria with L-arginine did not increase the mtNOS activity, as suggested in earlier studies [39, 40] . We tested whether presence of 1 to 5 mM Mg 2+ in the buffers used in those studies could affect heart mtNOS activity. Fig. 3A shows that 1 mM Mg 2+ fully prevented Ca 2+ -induced mtNOS stimulation. Mg 2+ is a well-known mitochondrial Ca 2+ uptake blocker [41, 42] , and blockade of mitochondrial Ca 2+ uptake significantly decreases mtNOS activity [37, 38] Fig. 4A shows that mitochondria incu- [46] , tamoxifen increases the release of [Ca 2+ ] m from the granules in mitochondria of cancer cells [7] , and hypoxia increases the number and extent of the granules [43] . The results presented in Fig.  4D show a marked increase in [Ca 2+ ] m during reoxygenation, suggesting that reoxygenation shifts ionized/non-ionized equilibrium in the favor of ionized calcium.
Results presented in this study indicate that mitochondria respond to H/R by increasing [Ca 2+ ] m , that stimulates mtNOS activity leading to the elevation of mitochondrial peroxinitrite followed by oxidative stress and apoptosis (Scheme 2). This novel mechanism might contribute to the oxidative stress of cardiac cells during H/R.
